Arcellx (ACLX) Amortizatization of Intangibles (2021 - 2025)
Arcellx's quarterly Amortizatization of Intangibles came in at $1.2 million in Q4 2025, down 65.13% year-on-year from $3.6 million in Q4 2024, and down 81.77% quarter-over-quarter from $6.8 million in Q3 2025.
Arcellx has reported Amortizatization of Intangibles for 5 years, with the latest figure at $1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 65.13% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $8.4 million (down 45.38% YoY), and the FY2025 full-year result was $8.4 million, down 45.38% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $1.2 million, down from $6.8 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $6.8 million in Q3 2025, with the low at -$1.4 million in Q2 2023.
- Average Amortizatization of Intangibles over 5 years is $2.1 million, with a median of $1.2 million recorded in 2025.
- Peak annual rise in Amortizatization of Intangibles reached 1898.18% in 2023, while the deepest fall reached 2056.94% in 2023.
- Tracing ACLX's Amortizatization of Intangibles over 5 years: stood at -$150000.0 in 2021, then sank by 90.0% to -$285000.0 in 2022, then surged by 1483.86% to $3.9 million in 2023, then decreased by 9.53% to $3.6 million in 2024, then sank by 65.13% to $1.2 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $1.2 million (Q4 2025), $6.8 million (Q3 2025), and $188000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 188,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 3.57 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | -1.41 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | -285,000.00 |
| Dec 31, 2022 | -285,000.00 |
| Sep 30, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 72,000.00 |
| Jun 30, 2022 | 72,000.00 |
| Mar 31, 2022 | -110,000.00 |
| Mar 31, 2022 | -110,000.00 |
| Dec 31, 2021 | -150,000.00 |
| Dec 31, 2021 | -150,000.00 |